chr9-134796731-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000093.5(COL5A1):​c.2845-117A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.513 in 987,228 control chromosomes in the GnomAD database, including 132,268 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.52 ( 20867 hom., cov: 32)
Exomes 𝑓: 0.51 ( 111401 hom. )

Consequence

COL5A1
NM_000093.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -2.78

Publications

5 publications found
Variant links:
Genes affected
COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
COL5A1 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome, classic type
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, PanelApp Australia, Genomics England PanelApp
  • Ehlers-Danlos syndrome, classic type, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • arterial disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant 9-134796731-A-G is Benign according to our data. Variant chr9-134796731-A-G is described in ClinVar as Benign. ClinVar VariationId is 672276.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.753 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL5A1NM_000093.5 linkc.2845-117A>G intron_variant Intron 35 of 65 ENST00000371817.8 NP_000084.3 P20908-1A0A024R8E5B2ZZ86Q59EE7
COL5A1NM_001278074.1 linkc.2845-117A>G intron_variant Intron 35 of 65 NP_001265003.1 B2ZZ86Q59EE7
COL5A1XM_017014266.3 linkc.2845-117A>G intron_variant Intron 35 of 64 XP_016869755.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL5A1ENST00000371817.8 linkc.2845-117A>G intron_variant Intron 35 of 65 1 NM_000093.5 ENSP00000360882.3 P20908-1
COL5A1ENST00000371820.4 linkc.2845-117A>G intron_variant Intron 35 of 65 2 ENSP00000360885.4 P20908-2H7BY82

Frequencies

GnomAD3 genomes
AF:
0.520
AC:
79047
AN:
151924
Hom.:
20852
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.571
Gnomad AMI
AF:
0.297
Gnomad AMR
AF:
0.449
Gnomad ASJ
AF:
0.539
Gnomad EAS
AF:
0.773
Gnomad SAS
AF:
0.552
Gnomad FIN
AF:
0.458
Gnomad MID
AF:
0.522
Gnomad NFE
AF:
0.496
Gnomad OTH
AF:
0.511
GnomAD4 exome
AF:
0.512
AC:
427645
AN:
835186
Hom.:
111401
AF XY:
0.513
AC XY:
225492
AN XY:
439414
show subpopulations
African (AFR)
AF:
0.573
AC:
12330
AN:
21530
American (AMR)
AF:
0.466
AC:
19372
AN:
41562
Ashkenazi Jewish (ASJ)
AF:
0.536
AC:
11738
AN:
21888
East Asian (EAS)
AF:
0.762
AC:
27968
AN:
36720
South Asian (SAS)
AF:
0.545
AC:
39597
AN:
72654
European-Finnish (FIN)
AF:
0.456
AC:
23415
AN:
51298
Middle Eastern (MID)
AF:
0.532
AC:
2239
AN:
4206
European-Non Finnish (NFE)
AF:
0.495
AC:
270262
AN:
545594
Other (OTH)
AF:
0.522
AC:
20724
AN:
39734
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
12172
24345
36517
48690
60862
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5012
10024
15036
20048
25060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.520
AC:
79113
AN:
152042
Hom.:
20867
Cov.:
32
AF XY:
0.518
AC XY:
38531
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.571
AC:
23688
AN:
41462
American (AMR)
AF:
0.450
AC:
6874
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.539
AC:
1870
AN:
3470
East Asian (EAS)
AF:
0.773
AC:
3982
AN:
5154
South Asian (SAS)
AF:
0.551
AC:
2655
AN:
4820
European-Finnish (FIN)
AF:
0.458
AC:
4848
AN:
10590
Middle Eastern (MID)
AF:
0.514
AC:
151
AN:
294
European-Non Finnish (NFE)
AF:
0.496
AC:
33696
AN:
67948
Other (OTH)
AF:
0.511
AC:
1078
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1955
3909
5864
7818
9773
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
704
1408
2112
2816
3520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.517
Hom.:
2675
Bravo
AF:
0.523
Asia WGS
AF:
0.653
AC:
2268
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.97
CADD
Benign
0.15
DANN
Benign
0.20
PhyloP100
-2.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3811161; hg19: chr9-137688577; COSMIC: COSV65667152; API